Analysts’ updated eps estimates for Saturday, September 9th:
Equifax (NYSE:EFX) had its outperform rating reiterated by analysts at Evercore ISI. They currently have a $174.00 target price on the stock.
Genel Energy (NASDAQ:GEGYY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Genel Energy PLC is an oil and gas exploration and production company. It reserves and resources located primarily in the Kurdistan Region of Iraq. Genel Energy PLC is headquartered in London. “
Heico Corporation (NYSE:HEI) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Heico Corporation is engaged primarily in certain niche segments of the aviation, defense, space and electronics industries through its Hollywood, FL-based HEICO Aerospace Holdings Corp. subsidiary and its Miami, FL-based HEICO Electronic Technologies Corp. subsidiary. HEICO’s customers include a majority of the world’s airlines and airmotives as well as numerous defense and space contractors and military agencies worldwide in addition to telecommunications, electronics and medical equipment manufacturers. “
HALMA (NASDAQ:HLMAF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Halma PLC is a health and safety sensor technology company. It manufactures products which detect hazards and also protect assets and people at work in public and commercial buildings. Halma PLC is headquartered in Amersham, the United Kingdom. “
Hammerson (NASDAQ:HMSNF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Hammerson plc is a real estate investment trust. The company’s portfolio includes commercial buildings, offices and shopping centers. It operates primarily in United Kingdom, Germany and France. Hammerson plc is based in London, the United Kingdom. “
Histogenics Corporation (NASDAQ:HSGX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Histogenics Corporation is a regenerative medicine company. It is focused on developing and commercializing products in the musculoskeletal segment. The company is developing NeoCart(R) product to provide treatment in the orthopedic space. Histogenics Corporation is headquartered in Waltham, Massachusetts. “
Intertek Gp Plc (OTCMKTS:IKTSY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Intertek Group plc provides assurance, testing, inspection and certification solutions. It serves laboratories and offices. Intertek Group plc is headquartered in London, the United Kingdom. “
IMI Plc (NASDAQ:IMIAY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “IMI PLC is an engineering company. It provides designs, manufactures and services for engineered products which control the movement of fluids. The company primarily serves energy, transportation and infrastructure sector. IMI PLC is headquartered in Birmingham, the United Kingdom. “
Jagged Peak Energy (NYSE:JAG) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Jagged Peak Energy Inc. is an oil and natural gas company. It focused on the acquisition and development of unconventional oil and associated liquids-rich natural gas reserves in the Southern Delaware Basin, a sub-basin of the Permian Basin of West Texas. Jagged Peak Energy Inc. is based in Denver, United States. “
Quaker Chemical Corporation (NYSE:KWR) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Quaker Chemical Corp. develops, produces, and markets a broad range of formulated chemical specialty products for various heavy industrial and manufacturing applications and, in addition, offers and markets chemical management services. Quaker’s principal products and services include: rolling lubricants, corrosion preventives, metal finishing compounds, machining and grinding compounds, forming compounds, hydraulic fluids, technology for the removal of hydrogen sulfide, chemical milling maskants, construction products and programs to provide chemical management services. “
Mastercard (NYSE:MA) had its buy rating reiterated by analysts at Instinet. The firm currently has a $163.00 target price on the stock, up from their previous target price of $153.00.
Proofpoint (NASDAQ:PFPT) had its outperform rating reiterated by analysts at FBN Securities. They currently have a $105.00 price target on the stock, up from their previous price target of $100.00.
